The document describes a proposed mobile diagnostic device from the Hranitel group in Moscow. It would allow remote monitoring of vital signs and diagnosis of medical conditions using sensors, mobile devices, and cloud resources. Key features include non-invasive ECG and blood glucose monitoring. A team of doctors and engineers will develop the hardware, sensors, and diagnostic software. The business plan envisions individual and clinical use, with distribution through online sales, distributors, and government programs. Risks like sensor development delays will be mitigated through iterative design. The total projected budget is 38,500 thousand rubles over 3 years.